Would you consider PD-L1 score when deciding whether to incorporate durvalumab in first-line metastatic biliary cancer?  

If so, what assay would you use in this population?

Do we have data on TMB/PDL1 status of long-term survivors?



Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution